Andere talen Edwards Lifesciences Corporation Wiener Boerse

Aandelen

EWLS

US28176E1082

slotkoers Wiener Boerse Andere beurzen 00:00:00 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
79,44 ^EUR	-0,23%		+0,43%	+14,50%

09/05	Edwards Lifesciences Corporation lanceert de SAPIEN 3 Ultra RESILIA-klep in Europa met technologie om de duurzaamheid te verbeteren	CI
07/05	EDWARDS LIFESCIENCES CORPORATION : Barclays herhaalt het Neutraal advies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Edwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vor	09/05
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing	01/05
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing	30/04
Well, it isn't as bad as feared...	26/04
Alphabet : ExxonMobil, Microsoft...les valeurs à suivre aujourd'hui à Wall Street	26/04
STATI UNITI. - I titoli da tenere d'occhio a Wall Street	26/04
EE.UU. - Valores a seguir en Wall Street	26/04
Edwards Lifesciences : relève ses prévisions de ventes après un bon premier trimestre	26/04
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	26/04
Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set	25/04
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Posts Q1 EPS $0.66, vs. Street Est of $0.64	25/04
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Reports Q1 Revenue $1.6B, vs. Street Est of $1.57B	25/04
Edwards Lifesciences: Q1 Earnings Snapshot	25/04
Edwards Lifesciences Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Edwards Lifesciences Reports First Quarter Results	25/04
Edwards Lifesciences Corporation Revises Earnings Guidance for the Full Year 2024	25/04
Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024	25/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Headlines

Edwards Lifesciences Corporation: het verhaal gaat verder

23 april 2024 om 21:00 uur